Liposarcoma Treatment Market

Liposarcoma Treatment Market: Global Industry Analysis and Forecast 2016 - 2022

ID: PMRREP10109

Upcoming

Author : Abhijeet Surwase

Introduction

Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs. According to WHO, liposarcoma is the most common type of sarcomas (cancer of soft tissue) and accounts for approximately 17-20% of all cases of sarcoma. However, WHO classifies liposarcoma in the rare diseases as the incidence rate of the disease is as low as 2.5 per Mn population.

Liposarcoma most commonly occurs in the middle age or adults above the age of 40 and it can be well diagnosed with the help of excision biopsy. Liposarcoma can be of four types viz. well differentiated liposarcoma, myxoid liposarcoma, pleomorphic liposarcoma and dedifferentiated liposarcoma.

The most common drugs used for the treatment of liposarcoma include ifosfamide and doxorubicin. Ifosfamide is often prescribed in combination with uromitexan in order to prevent bladder irritation and internal bleeding. Moreover, cisplatin, vincristine, etoposide, gemcitabine, docetaxel etc. can be used to prevent the recurrence of liposarcoma.

The market for liposarcoma is highly fragmented with large number of generic manufacturers. The global market for liposarcoma treatment is expected to grow moderately over the forecast period owing to low incidence rate of the disease.

Some other factors which are anticipated to influence growth of global liposarcoma treatment market include lifestyle changes, incidence of genetic disorders, growing awareness through liposarcoma genome project etc. However, high cost of the treatment can be the major restraint for the growth of global liposarcoma treatment market.

The report covers exhaustive analysis on:

  • Liposarcoma Treatment Market Segments
  • Liposarcoma Treatment Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Liposarcoma Treatment Market Size & Forecast 2016 to 2022
  • Liposarcoma Treatment Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Liposarcoma Treatment Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Market Segmentation
Based on treatment type
  • Chemotherapy
  • Radiation Therapy
  • Surgical Therapy
Based on the end user type
  • Hospitals
  • Multispecialty Clinics
  • Cancer treatment and rehabilitation centers
Based on geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Surgical therapy treatment segment is expected to account for major share in global liposarcoma treatment market as it is the choice of treatment recommended by majority of cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma treatment however, it can be used prior to the surgery to reduce the size of the tumor making it the second largest segment in terms of value in global liposarcoma treatment market. Radiation therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a minimal share in global liposarcoma treatment market.

North America is anticipated to lead the global liposarcoma treatment market due to relatively greater prevalence of the disease in the region. APAC and MEA regions are expected to witness steady market growth owing to lack of awareness about the disease.

Some of the key players in global liposarcoma treatment market include Eli Lilly and Company, Baxter International, Bristol Laboratories Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Actavis plc.,Fresenius Kabi Ltd., Accord Healthcare Inc., Taro Pharmaceuticals Inc., Sandoz, Bedford Laboratories  and others. Recently FDA approved the new indication of Halaven (eribulin) to Esai Co. Ltd. and new drug application of Yondelis (Trabectedin) from Johnson & Johnson Private Limited for use in Europe, Russia and South Korea.

Related Reports

N/A

Research Methodology Framework for Market Research Excellence

At Persistence Market Research, we implement a comprehensive, validated, and multi-dimensional approachto market analysis that delivers actionable insights across complex market landscapes. Our methodology combines the analytical rigor of leading consulting firms with innovative research techniques, ensuring robust market assessments that guide strategic decision-making with confidence.

Core Research Philosophy

Our methodology is built on four foundational pillars:

Research Philosophy Image

At Persistence Market Research, our methodology is designed to transcend conventional market studies by combining analytical rigor, multi-source validation, and future-focused insights.

We integrate advanced research frameworks, robust data collection strategies, cutting-edge analytics, and innovative technologies to deliver a 360-degree view of complex markets.

We integrate advanced research frameworks, robust data collection strategies, cutting-edge analytics, and innovative technologies to deliver a 360-degree view of complex markets.

Each stage spanning from strategic scoping and hypothesis-building to competitive intelligence, quality validation, and actionable recommendations is engineered to provide clients with unmatched clarity, precision, and confidence in decision-making.

By embedding innovation and technology at the core, our approach ensures that insights are not only comprehensive but also predictive, empowering businesses to seize opportunities, mitigate risks, and achieve sustainable growth

Research Philosophy Image

Capturing Key Information and Events

During this phase, key research objectives focus on essential information and data points for assessing the market, including:

Research Philosophy Image

TAM-SAM-SOM Framework Implementation

We employ both top-down and bottom-up approaches to ensure accurate market sizing.

Top-Down Market SizingBottom-Up Market Sizing
Universe Definition: Total global/regional market identificationUnit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraintsCustomer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocationPenetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptionsScaling Methodology: Extrapolation techniques with confidence intervals

Validation & Cross-Verification

  • Triangulation: Comparing top-down and bottom-up results for consistency
  • Sensitivity Analysis: Testing key assumptions and parameter variations
  • Peer Benchmarking: Comparison with analogous markets and industry benchmarks
  • Expert Review: External validation through industry specialist consultation

Research Philosophy Image

Forecasting & Projection Modeling

Our proprietary forecasting models incorporate multiple variables and scenarios.

Forecasting Components

  • Historical Trend Analysis: 10-year historical growth patterns and cyclical variations
  • Driver-Based Modeling: Economic indicators, demographic shifts, technology adoption
  • Scenario Planning: Base case, optimistic, and conservative projections
  • Monte Carlo Simulations: Probability-weighted outcomes and risk assessments

Model Validation

  • Back-Testing: Historical accuracy assessment over 3–5-year periods
  • Cross-Validation: Multiple modeling approaches for result comparison
  • External Benchmarking: Comparison with established market forecasts
  • Continuous Calibration: Quarterly model updates based on new data

Comprehensive Data Collection Strategy

Our secondary research phase establishes a robust knowledge base utilizing diverse, credible sources.

Secondary Data Sourcess

  • Industry Publications & Reports
  • Government & Regulatory Data
  • Financial Intelligence (filings & reports)
  • Academic Research & Digital Intelligence

Quality Assurance Protocol

  • Source credibility assessment and publication date validation
  • Data consistency checks across multiple sources
  • Bias identification and neutralization techniques
  • Information gap tracking for primary research prioritization

Research Philosophy Image

Primary Research Excellence

Our primary research methodology employs best-in-class techniques to capture unique market insights.

Quantitative Research Methods

  • Large-Scale Surveys: Statistically representative samples with 95% confidence intervals
  • Survey Methodology: Multi-channel deployment (online, telephone, in-person)
  • Question Architecture and Response Optimization

Qualitative Research Methods

  • Executive Interviews
  • Focus Groups
  • Expert Consultations

Quality Assurance & Validation Framework

Multi-Stage Validation Process

  • Source Verification and Consistency Testing
  • Outlier Detection and Bias Assessment
  • Peer Review Process and External Validation
  • Sensitivity Analysis and Confidence Intervals

Research Philosophy Image

Methodology Validation & Credibility

Our research methodology has been extensively validated through:

  • Academic Partnerships: Collaborations with top-tier business schools and research institutions
  • Client Success Stories: Documented case studies demonstrating research impact and ROI
  • Continuous Benchmarking: Performance comparison with leading global research firms

This comprehensive methodology framework positions Persistence Market Research at the forefront of market intelligence, combining the analytical sophistication of top-tier consulting firms with innovative research techniques. Our approach ensures that every market assessment delivers precise, actionable, and strategically valuable insights that drive business success in competitive market environments.

Ready to unlock your market potential? Contact our research experts to discuss how our validated methodology can transform your strategic decision-making with data-driven market intelligence.

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -